Cell/Gene Tx channel feed – Endpoints News

Cell/Gene Tx channel feed

Even FDA's Peter Marks is worried about the commercial viability of gene and cell therapies

4 years ago

Cell and gene therapy consulting firm submits draft AAV purity guidance to FDA

4 years ago

With $270M in new funds, Shankar Ramaswamy looks beyond Roivant in scaling his gene therapy 'consolidated engine'

4 years ago

Caribou aces its first round of human data in search of an off-the-shelf CAR-T breakthrough

4 years ago

Sana's Terry Fry leads new $200M cell and gene therapy institute at University of Colorado

4 years ago

Verve gets New Zealand clearance to test base editing therapy directly in the human body

4 years ago

Months later, LogicBio exits FDA clinical hold for gene editing drug but won't restart trial until next quarter

4 years ago

Exclusive: Aspen Neuroscience collects large Series B to compete against Bayer's Parkinson's cell therapy

4 years ago

FDA releases second Pfizer gene therapy from clinical hold, as hemophilia program gets OK to restart

4 years ago

Still-in-stealth biotech partners with Sloan Kettering scientists to make personalized cancer therapy more ‘public’

4 years ago

FDA puts a hold on Vertex’s attempted diabetes cure

4 years ago

Scoop: After failing to secure more funds, a private gene therapy developer lays off staff

4 years ago

Pfizer can restart PhIII trial of Duchenne gene therapy, now on track for late-2023 FDA approval request

4 years ago

BioMarin plots comeback year, with plans to turn around profits and head back to the FDA with rejected gene therapy

4 years ago

Axovant-turned-Sio ditches two remaining programs, lays off most employees and will seek a buyer

4 years ago

Deerfield-backed biotech emerges from stealth with gene therapy delivery platforms from Harvard and MIT

4 years ago

Nkarta reveals its first off-the-shelf NK cell data, showing multiple complete responses — shares soar

4 years ago

New paper sheds fresh light on Tmunity's high-profile CAR-T deaths

4 years ago

FDA signs off on Gilead's massive new CAR-T manufacturing site in Maryland

4 years ago

New T cell immune response discovery points to 'out-of-box' cancer therapy options

4 years ago

With boosted biodefense work, Heat Bio ices its name in favor of NightHawk

4 years ago

Welcome to 'tissue therapeutics’: Dave Lennon’s $110M new venture will implant ‘happy cells’ that ‘survive and thrive’

4 years ago

Flagship-founded Tessera fuels up with $300M 'to go on a really big adventure' in gene editing

4 years ago

'Timing couldn't be better': An ex-generics maker goes SPAC route with blank check intended for sports market

4 years ago

First page Previous page 29 30 313233 34 35 Next page Last page